Lyell Immunopharma (LYEL) Other Non-Current Liabilities (2020 - 2026)
Lyell Immunopharma (LYEL) reported Other Non-Current Liabilities of $537,000 for Q2 2026, down 90.3% from $5.53 million a year earlier but up 1.9% from the prior quarter.
Lyell Immunopharma (LYEL) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
At the end of FY2025, Lyell Immunopharma posted Other Non-Current Liabilities of $517,000, down 93.2% from FY2024.
- Other Non-Current Liabilities has a five-year compound annual growth rate of -0.6% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $7.6 million in FY2024 (+107.4%), $3.66 million in FY2023 (-10.9%), $4.11 million in FY2022 (-9.9%) and $4.57 million in FY2021 (+758.3%).
- Five-year quarterly Other Non-Current Liabilities spans a low of $517,000 in Q4 2025 and a high of $7.6 million in Q4 2024.
- Year over year, Other Non-Current Liabilities has now declined in each of the last four quarters, with an average decline of 7.2% over the last eight quarters.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q4 2021 (growth of 758.3%); the low point was Q4 2025 (a decline of 93.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $527,000 (Q1 2026), $517,000 (Q4 2025) and $2.68 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Lyell Immunopharma | 229.06 Mn | 229.06 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 537,000.00 |
| Mar 31, 2026 | 527,000.00 |
| Dec 31, 2025 | 517,000.00 |
| Sep 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | 5.53 Mn |
| Mar 31, 2025 | 6.39 Mn |
| Dec 31, 2024 | 7.60 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Jun 30, 2024 | 3.44 Mn |
| Mar 31, 2024 | 3.55 Mn |
| Dec 31, 2023 | 3.66 Mn |
| Sep 30, 2023 | 3.78 Mn |
| Jun 30, 2023 | 3.89 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 4.11 Mn |
| Sep 30, 2022 | 4.23 Mn |
| Jun 30, 2022 | 4.34 Mn |
| Mar 31, 2022 | 4.45 Mn |
| Dec 31, 2021 | 4.57 Mn |
| Sep 30, 2021 | 5.01 Mn |
Lyell Immunopharma Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LYEL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();